Adverse Drug Reactions Advisory Committee
From Wikipedia, the free encyclopedia
The Adverse Drug Reactions Advisory Committee or ADRAC is a subcommittee of the Australian Drug Evaluation Committee (ADEC) which monitors the safety of medicines in Australia. ADRAC evaluates reports from the Adverse Drug Reactions Unit of the Therapeutic Goods Administration (TGA), which administers the adverse drug reaction (ADR) reporting system in Australia, and may make recommendations regarding the medication including withdrawal of medications from the market. ADRAC also publishes the Australian Adverse Drug Reactions Bulletin to raise awareness of medication safety issues and ADR reports.
[edit] External links
- ADRAC website
- Australian Adverse Reactions Bulletin
- The Medical Letter's Adverse Drug Interactions Database
 |
This Australian government-related article is a stub. You can help Wikipedia by expanding it. |
